Harlan S Robins Adaptive Biotechnologies Corp (ADPT) insider trading activity

ADPT Quotes by TradingView

Harlan S Robins is Chief Scientific Officer of Adaptive Biotechnologies Corp. Currently has a direct ownership of 1.28 Million shares of ADPT, which is worth approximately $13.6 Million. The most recent transaction as insider was on Jan 21, 2021, when has been sold 23,370 shares (Common Stock) at a price of $66.85 per share, resulting in proceeds of $1,562,284. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.28M
0% 3M change
25.3% 12M change
Total Value Held $13.6 Million

HARLAN S ROBINS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 21 2021
SELL
Open market or private sale
$1,562,284 $66.85 p/Share
23,370 Reduced 97.18%
679 Common Stock
Jan 21 2021
BUY
Exercise of conversion of derivative security
$147,698 $6.32 p/Share
23,370 Added 49.28%
24,049 Common Stock
Jan 20 2021
SELL
Open market or private sale
$3,374,000 $67.48 p/Share
50,000 Reduced 98.66%
679 Common Stock
Jan 20 2021
BUY
Exercise of conversion of derivative security
$316,000 $6.32 p/Share
50,000 Added 49.66%
50,679 Common Stock
Jan 19 2021
SELL
Open market or private sale
$3,447,500 $68.95 p/Share
50,000 Reduced 98.66%
679 Common Stock
Jan 19 2021
BUY
Exercise of conversion of derivative security
$316,000 $6.32 p/Share
50,000 Added 49.66%
50,679 Common Stock
Nov 06 2020
SELL
Open market or private sale
$571,872 $51.52 p/Share
11,100 Reduced 94.24%
679 Common Stock
Nov 06 2020
BUY
Exercise of conversion of derivative security
$70,152 $6.32 p/Share
11,100 Added 48.52%
11,779 Common Stock
Nov 05 2020
SELL
Open market or private sale
$559,884 $50.44 p/Share
11,100 Reduced 94.24%
679 Common Stock
Nov 05 2020
BUY
Exercise of conversion of derivative security
$70,152 $6.32 p/Share
11,100 Added 48.52%
11,779 Common Stock
Nov 04 2020
SELL
Open market or private sale
$561,549 $50.59 p/Share
11,100 Reduced 94.24%
679 Common Stock
Nov 04 2020
BUY
Exercise of conversion of derivative security
$70,152 $6.32 p/Share
11,100 Added 48.52%
11,779 Common Stock
Oct 16 2020
SELL
Open market or private sale
$574,869 $51.79 p/Share
11,100 Reduced 94.24%
679 Common Stock
Oct 16 2020
BUY
Exercise of conversion of derivative security
$70,152 $6.32 p/Share
11,100 Added 48.52%
11,779 Common Stock
Oct 15 2020
SELL
Open market or private sale
$572,205 $51.55 p/Share
11,100 Reduced 94.24%
679 Common Stock
Oct 15 2020
BUY
Exercise of conversion of derivative security
$70,152 $6.32 p/Share
11,100 Added 48.52%
11,779 Common Stock
Oct 14 2020
SELL
Open market or private sale
$581,196 $52.36 p/Share
11,100 Reduced 94.24%
679 Common Stock
Oct 14 2020
BUY
Exercise of conversion of derivative security
$70,152 $6.32 p/Share
11,100 Added 48.52%
11,779 Common Stock
HSR

Harlan S Robins

Chief Scientific Officer
Seattle, WA

Track Institutional and Insider Activities on ADPT

Follow Adaptive Biotechnologies Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

News

Receive news related to Adaptive Biotechnologies Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADPT